Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Apr 16, 2008

BioTime Opens Embryonic Stem Cell Technology Production Site in California

  • BioTime reports that it has opened an 11,000 sq. ft. tissue culture GMP-capable facility in Alameda, CA. The site is certified as Class 1000 and Class 10,000 laboratory space and includes cell culture and manufacturing equipment.

    BioTime’s subsidiary, Embryome Sciences, will use the plant for the production and marketing of embryonic progenitor cells, progenitor cell lines, and products derived from those embryonic progenitor cell lines. The products developed in the new facility will be produced and sold for research purposes.

    BioTime plans to move its headquarters from its current location in Emeryville, CA, to this new space.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »